D
Apogee Therapeutics, Inc. APGE
$39.94 $1.614.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 20.66% 18.83%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 29.30% 33.01%
Operating Income -29.30% -33.01%
Income Before Tax -37.09% -44.96%
Income Tax Expenses -- --
Earnings from Continuing Operations -37.13% -44.96%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -37.13% -44.96%
EBIT -29.30% -33.01%
EBITDA -29.28% -33.01%
EPS Basic -36.03% -44.23%
Normalized Basic EPS -36.00% -44.22%
EPS Diluted -36.03% -44.23%
Normalized Diluted EPS -36.00% -44.22%
Average Basic Shares Outstanding 0.80% 0.50%
Average Diluted Shares Outstanding 0.80% 0.50%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings